Truist Securities Maintains Hold on NuVasive, Raises Price Target to $51
Portfolio Pulse from richadhand@benzinga.com
Truist Securities analyst Richard Newitter maintains a 'Hold' rating on NuVasive (NASDAQ:NUVA) and raises the price target from $48 to $51.
July 19, 2023 | 1:51 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
The 'Hold' rating on NuVasive is maintained by Truist Securities, with a raised price target from $48 to $51.
The news directly pertains to NuVasive. The maintained 'Hold' rating indicates that the analyst believes the stock will perform in line with the market, while the raised price target suggests a slightly more optimistic outlook. However, as it's not a rating upgrade, the impact on the stock price might be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100